SL
Steven Lichtman Oppenheimer Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
DexCom
DXCM
$31.6B
| $80.51 | $102 |
27%
upside
| Outperform | 1 month ago |
|
2
Boston Scientific
BSX
$159B
| $107.22 | $118 |
10%
upside
| Perform | 1 month ago |
|
3
Insulet
PODD
$24.5B
| $348.43 | $324 |
7%
downside
| Outperform | 4 months ago |
|
4
Zimmer Biomet
ZBH
$20.9B
| $105.73 | $135 |
28%
upside
| Outperform | 10 months ago |
|
5
MannKind Corp
MNKD
$1.7B
| $5.54 | $12 |
117%
upside
| Outperform | 1 year ago |
|
6
Alcon
ALC
$39.6B
| $80.17 | $110 |
37%
upside
| Outperform | 1 year ago |
|
7
Medtronic
MDT
$119B
| $92.90 | $94 |
1%
upside
| Perform | 1 year ago |
|
8
RxSight
RXST
$364M
| $8.89 | $65 |
631%
upside
| Outperform | 1 year ago |
|
9
Tandem Diabetes Care
TNDM
$850M
| $12.58 | $58 |
361%
upside
| Outperform | 1 year ago |
|
|
BWAY
10
Brainsway
BWAY
$300M
| $15.85 | $11 |
31%
downside
| Outperform | 1 year ago |
|
11
AngioDynamics
ANGO
$436M
| $10.73 | $12 |
12%
upside
| Outperform | 1 year ago |
|
12
Merit Medical Systems
MMSI
$5.51B
| $92.97 | $87 |
6%
downside
| Outperform | 1 year ago |
|
13
Stryker
SYK
$150B
| $392.31 | $288 |
27%
downside
| Perform | 4 years ago |
|
14
Glaukos
GKOS
$5.39B
| $93.94 | $105 |
12%
upside
| Perform | 4 years ago |
|
15
STAAR Surgical
STAA
$1.38B
| $27.94 | $150 |
437%
upside
| Perform | 4 years ago |
|
16
Cooper Companies
COO
$13.5B
| $68.09 | $85 |
25%
upside
| Perform | 5 years ago |
|